TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06549790: Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia

Sponsor: Nerviano Medical Sciences · Phase: PHASE1 · Area: ONCOLOGY · Target Enrollment: 124 pts

Competing Trials Overlap

6 Active Trials

Excess Burn Exposure

$10,053,120

Rescue Site Savings

+$6,628,776

Unlock Full NCT06549790 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06549790 Rescue Dossier →